Filing Details

Accession Number:
0001513162-20-000217
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-27 18:34:49
Reporting Period:
2020-10-26
Accepted Time:
2020-10-27 18:34:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
73290 Biomerica Inc BMRA In Vitro & In Vivo Diagnostic Substances (2835) 952645573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821432 Catherine Coste 17571 Von Karman Avenue
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-26 9,100 $5.45 9,100 No 4 P Indirect See Note 1.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 1.
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock option $0.00 2030-08-27 0 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2030-08-27 0 25,000 Direct
Footnotes
  1. Shares were purchased through spouse's retirement account.
  2. Not applicable
  3. Exercisable at various dates.